Form 483

CTK OTC Laboratories LLC Form 483, 2026-05-04

FDA issued a Form 483 to CTK OTC Laboratories LLC on 2026-05-04 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

CTK OTC Laboratories LLC · Corona, United States · Issued May 4, 2026

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 May 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Ngozi G Offor

4 May 2026
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Ngozi G Offor

4 May 2026
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Ngozi G Offor

4 May 2026
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Ngozi G Offor

Inspected site

COCTK OTC Laboratories LLCCorona, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere